|  |  | 

India Top Headlines

Covid-19: The government seals an agreement for 300 million doses of Biological-E vaccines | India News

BENGALURU: The Union Health Ministry said on Thursday that it signed an agreement with the national vaccine manufacturer Biological-E for 30 crore of Covid-19 vaccine doses.
These doses of vaccine will be manufactured and stored by Biological-E from August to December 2021.
The vaccine, which is currently in phase 3 clinical trials, will likely be available in the coming months, the Health Ministry said in a statement.
Biological-E, which also has a separate agreement to produce about 600 million doses of Johnson & Johnson’s Covid-19 vaccine annually, said Tuesday that it has signed a license agreement with Providence Therapeutics Holdings to manufacture the Covid mRNA vaccine. -19 from the Canadian company in India.
Biological-E will run a clinical trial of the Providence vaccine in India and seek approval for emergency use.
(With inputs from agencies)

Reference page